Pediapharm Inc. (CVE:PDP – Get Free Report) rose 1.7% during mid-day trading on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12. The stock has a fifty day simple moving average of C$0.30 and a two-hundred day simple moving average of C$0.30. The stock has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Featured Stories
- Five stocks we like better than Pediapharm
- 5 Top Rated Dividend Stocks to Consider
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oilfield Leader SLB: An AI Name You Need to Know
- Options Trading – Understanding Strike Price
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
